Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Predictive Significance of Combined Plasmatic Detection of BRAF Mutations and S100B Tumor Marker in Early‐Stage Malignant Melanoma

Cancer Medicine(2024)10.1002/cam4.70313Source: DataRank Database

Predictive Significance of Combined Plasmatic Detection of BRAF Mutations and S100B Tumor Marker in Early‐Stage Malignant Melanoma is a research paper published in Cancer Medicine (2024). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: goldTopics (45)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Mohamed A. Gouda ORCID,Mahyar Sharif Bagheri ORCID,Martin Pešta ORCID,Helen J. Huang ORCID,Inka Třešková ORCID

Live enrichment

PubMed:39387479 PMC:PMC11465285

National Institutes of Health

Grant: 3P30CA016672-41S4

Cancer Center Support (CORE) Grant

This work was supported by LTAUSA19080 program, INTEREXCELLENCE, INTER-ACTION, Ministry of Education, Youth and Sports of the Czech Republic; by Cooperation Programme, research areas MED/DIAG, MED/ONCO and MED/SURG Charles University; by a grant of the Ministry of Health of the Czech Republic-Conceptual Development of Research Organization (Faculty Hospital in Pilsen-FNPl, 00669806) and by National Institutes of Health through MD Anderson's Cancer Center Support Grant [grant number P30CA016672

goldLicense: cc-by

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.70313

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.70313

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11465285/pdf/CAM4-13-e70313.pdf

Unpaywallhttps://doi.org/10.1002/cam4.70313

Europe_PMChttps://europepmc.org/articles/PMC11465285

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansMelanomaSkin NeoplasmsNeoplasm Recurrence, LocalProto-Oncogene Proteins B-rafNeoplasm StagingPrognosisPredictive Value of TestsMutationAdultAgedAged, 80 and overMiddle AgedFemaleMaleS100 Calcium Binding Protein beta SubunitBiomarkers, TumorLiquid Biopsy

Keywords

MelanomactDNAS100BBraf V600eDdpcrProto-Oncogene Proteins B-rafMaleAdultSkin NeoplasmsS100 Calcium Binding Protein beta SubunitPredictive Value of TestsBiomarkers, TumorHumansRC254-282AgedNeoplasm StagingAged, 80 and overLiquid BiopsyNeoplasms. Tumors. Oncology. Including cancer and carcinogensMiddle AgedPrognosisMutationFemaleNeoplasm Recurrence, LocalResearch Article